Literature DB >> 2655186

Postischemic insulin reduces spatial learning deficit following transient forebrain ischemia in rats.

C L Voll1, I Q Whishaw, R N Auer.   

Abstract

We investigated the ability of postischemic insulin administration to modify the structural and neurobehavioral consequences of cerebral ischemia in rats. Forebrain ischemia was induced in fed rats by combining controlled systemic hypotension with bilateral carotid artery clamping for 10 1/2 minutes. Following clamp release, one group of six rats [corrected] was given insulin (2 IU/kg s.c. b.i.d.) for 1 week. An ischemic-control group of five rats [corrected] received no postischemic treatment. A sham-ischemia group of rats was used as a behavioral control. Throughout the recovery period until sacrifice, the drinking water of all rats was supplemented with 25% glucose. Rats were trained on two water maze place navigation tasks 1-2 months after ischemia. Escape latencies and swim patterns were recorded. Performance in the insulin-treated group was better than that in the ischemic-control group (p less than 0.05) on both tasks and did not differ significantly from that of the sham-ischemia group. Improvement in behavior correlated with a significant reduction in CA1 hippocampal necrosis in the insulin-treated group (p less than 0.05). Our findings demonstrate that postischemic treatment with insulin improves neurobehavioral performance in addition to lessening ischemic neuronal necrosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2655186     DOI: 10.1161/01.str.20.5.646

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

1.  Insulin protects cognitive function in experimental stroke.

Authors:  A J Strong; J E Fairfield; E Monteiro; M Kirby; A R Hogg; M Snape; L Ross-Field
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

2.  The management of plasma glucose in acute cerebral ischaemia and traumatic brain injury: more research needed.

Authors:  Anthony J Strong
Journal:  Intensive Care Med       Date:  2008-03-05       Impact factor: 17.440

3.  Neurotoxicity of Clostridium perfringens epsilon-toxin for the rat hippocampus via the glutamatergic system.

Authors:  O Miyamoto; J Minami; T Toyoshima; T Nakamura; T Masada; S Nagao; T Negi; T Itano; A Okabe
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  The Relationship Between the Decreased Rate of Initial Blood Glucose and Neurologic Outcomes in Survivors of Out-of-Hospital Cardiac Arrest Receiving Therapeutic Hypothermia.

Authors:  Jae-Hyug Woo; Yong Su Lim; Hyuk Jun Yang; Sung Youl Hyun; Jin Seong Cho; Jin Joo Kim; Gun Lee
Journal:  Neurocrit Care       Date:  2017-06       Impact factor: 3.210

Review 5.  Hyperglycemia, acute ischemic stroke, and thrombolytic therapy.

Authors:  Sherif Hafez; Maha Coucha; Askiel Bruno; Susan C Fagan; Adviye Ergul
Journal:  Transl Stroke Res       Date:  2014-03-13       Impact factor: 6.829

Review 6.  Bidirectional metabolic regulation of neurocognitive function.

Authors:  Alexis M Stranahan; Mark P Mattson
Journal:  Neurobiol Learn Mem       Date:  2011-01-12       Impact factor: 2.877

7.  Focal cerebral infarction in cats in the presence of hyperglycemia and increased insulin.

Authors:  D J Combs; R J Dempsey; S Kumar; D Donaldson
Journal:  Metab Brain Dis       Date:  1990-12       Impact factor: 3.584

Review 8.  Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration.

Authors:  Ilhan Akan; Stephanie Olivier-Van Stichelen; Michelle R Bond; John A Hanover
Journal:  J Neurochem       Date:  2017-11-20       Impact factor: 5.372

9.  The role of hyperglycemia in acute ischemic stroke.

Authors:  Rachel M Gilmore; Latha G Stead
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

10.  Cytochrome C is tyrosine 97 phosphorylated by neuroprotective insulin treatment.

Authors:  Thomas H Sanderson; Gargi Mahapatra; Petr Pecina; Qinqin Ji; Kebing Yu; Christopher Sinkler; Ashwathy Varughese; Rita Kumar; Melissa J Bukowski; Renee N Tousignant; Arthur R Salomon; Icksoo Lee; Maik Hüttemann
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.